The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2024 | Assessing vaccine delivery in lung cancer care
Adam Januszewski, St Bartholomew’s Hospital in London, discusses the use of vaccines in lung cancer medicine. While acknowledging the intriguing data on vaccine use, he highlights the need to assess the readiness of healthcare systems to deliver such treatments efficiently to lung cancer patients, who often present with frailty and comorbidities. While structures for vaccine delivery may exist, Dr Januszewski emphasizes the uncertainty surrounding their timely administration to patients who urgently require treatment. Thus, he suggests that the readiness of healthcare systems for vaccine delivery remains a subject of ongoing evaluation. This interview took place at the BTOG 2024 congress in Belfast, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
